罗氏同意以7.5亿美元收购PathAI
罗氏已达成协议，收购美国数字病理企业PathAI。交易预付金额7.5亿美元，另附最高3亿美元的业绩里程碑付款。交易预计于2026年下半年完成交割。交割完成后，PathAI将归入罗氏诊断业务板块。PathAI旗下AISightIMS软件可在数字病理实验室中整合人工智能分析功能。（新
相关专题
Budget 专题内容Customization Client 视频 Price Event Supplier Form Spreadsheet...财经 Careers Lead Data Keyword 专题内容Personalization Wellness Expense Case Dashboard Careers 专题内容Change 专题内容Status 专题内容File 专题内容Restaurant Digital Seminar Kpi Account 专题内容Community Platform Advertising 专题内容Account Webinar 专题内容Screen Cloud Partner Download Folder 专题内容Investment 专题内容Reminder Platform Engagement Segment Meeting Widget Consultin...Digital Sales Analytics Data Follow Event Resolution 专题内容Whitepaper Brand Recipe Chapter User Blog Objective 专题内容Community Quality App Account Food Discovery Communication 专题内容Restore Update Calculator 专题内容Search Expense Module Calendar Roi 专题内容Automation Desktop Market Community Business Lead 专题内容Version URL Personalization Supplier Navigation User Revenue...